爱尔兰爵士制药去纤苷多少钱一支？

(Defibrotide) is a biochemical drug derived from a mixture of single-stranded deoxyoligonucleotides. It mainly acts on endothelial cells and produces a variety of biological effects. Clinical research is mainly carried out around the indications of cardiovascular dysfunction. Clinical experiments have proven that defibrotide can effectively prevent and treat hepatic veno-occlusive disease (HVOD). On March 30, 2016, Irish Jazz Pharmaceuticals’ defibrotide was approved by the U.S. Food and Drug Administration (FDA) to be launched in the United States. So, how much does a pill of Irish Jazz Pharmaceuticals Defibrotide cost?

According to Medical Travel, the drug Defibrinoside, a drug owned by Irish Jazz Pharmaceuticals, has a specification of 200 mg and a price of about $22,000 each. It is not yet available in the country, so patients in need can only choose to purchase this version of the drug for use. In the actual purchase process, patients can either go abroad to purchase in person, or contact the medical companion tour to obtain their drug purchase channels.

Preclinical studies have confirmed that defibrotide has anti-thrombotic, fibrinolytic, anti-ischemic and anti-infective effects in vivo and in vitro. Defibrotide sodium is an adenosine receptor agonist with multiple effects. The adenosine A1/A2 receptors of endothelial cells are involved in the regulation of endothelial cells and the response of endothelial cells to injury. Defibrotide can act on these receptors to produce a variety of downstream effects. In a multi-institutional clinical study, 88 patients with severe HVOD were treated with defibrotide (intravenous medication, 5-60 mg/(kg·d), median application time was 15 days), the complete remission (CR) rate was 36%, the 100-day survival rate was 35%, and there were no obvious adverse reactions such as bleeding. In this regard, patients can purchase and use this medicine with confidence.

The owned company, Irish Jazz Pharmaceuticals, is a biopharmaceutical company. The company develops and commercializes products that address unmet medical needs. The company has a diverse portfolio of products and product candidates targeting the sleep and hematology/oncology areas.

Recommended hot articles: /newsDetail/87086.html